Full name
MIDAS PHARMA POLSKA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
46.18.Z - Activity of agents involved in wholesale trade of other specified goods
46.19.Z - Activity of agents involved in wholesale trade of non-specialized goods
46.46.Z - Wholesale trade of pharmaceutical and medical products
46.75.Z - Wholesale trade
74.90.Z - Other professional, scientific and technical activities, not elsewhere classified
77.40.Z - Leasing of intellectual property and similar products, excluding works protected by copyright
2020 | 2021 | 2022 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 3,5 | 4,3 | 5,7 | 33 |
EBITDA | 4,1 | 4 | 5,1 | 27,2 |
Short time liabilities | 8,2 | 8,8 | 9,7 | 9,9 |
Equity capital | 6,9 | 10,4 | 15 | 45 |
Operating profit (EBIT) | 4 | 3,9 | 5 | 28 |
Assets | 15,9 | 19,9 | 25,9 | 30,3 |
Net profit (loss) | 2,8 | 3,5 | 4,7 | 33,8 |
Cash | 3,6 | 5,9 | 8,6 | 45,4 |
Liabilities and provisions for liabilities | 9 | 9,5 | 10,9 | 14,3 |
Net income from sale | 75,3 | 67,5 | 75 | 11,2 |
Working assets | 15,4 | 19,5 | 25,5 | 31,1 |
Depreciation | 0,1 | 0,1 | 0,1 | -4,7 |
% | % | % | p.p. | |
Profitability of capital | 40,8 | 33,6 | 31 | -2,6 |
Equity capital to total assets | 43,3 | 52,2 | 58 | 5,8 |
Gross profit margin | 4,7 | 6,4 | 7,6 | 1,2 |
EBITDA Margin | 5,4 | 6 | 6,8 | 0,8 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 40 | 48 | 47 | -1 |
Current financial liquidity indicator | 1.7675395011901855 | 2.0885233879089355 | 2.3633298873901367 | 0,3 |
Net dept to EBITDA | -0.8341065049171448 | -1.4334173202514648 | -1.6684012413024902 | -0,3 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane